CSIMarket


Protagenic Therapeutics Inc new  (PTIX)
Other Ticker:  
 
    Sector  Services    Industry Professional Services
   Industry Professional Services
   Sector  Services


 

Protagenic Therapeutics Inc new

PTIX's Financial Statements and Analysis



Protagenic Therapeutics Inc new increased III. Quarter net loss per share of $-0.05 compare to net loss per share of $-0.05 recorded in the same quarter a year ago a decrease compare to $-0.04 realized in previous quarter.


III. Quarter
Earnings Per Share Revenues
$ -0.05 $  0 Mill
Unch.     Unch.    



Protagenic Therapeutics Inc New's Revenue fell by 0 % in III. Quarter (Sep 30 2022) year on year, to $0 million and declined by sequentially.


Protagenic Therapeutics Inc New is Expected to report next financial results on April 06, 2023.

More on PTIX's Income Statement



Protagenic Therapeutics Inc New's in III. Quarter recorded net loss of $-0.925 million, an increase from net loss of $-0.878 million in III. Quarter a year ago.

Sequentially net loss advanced

More on PTIX's Growth

In III. Quarter company's net cash and cash equivalents decreased by $0 million


Protagenic Therapeutics Inc new does not pay out common stock dividend.

In trailing twelve-month period Protagenic Therapeutics Inc new payed $ -0.13 cash per share, on a free-cash flow basis .